Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 233.50
Bid: 232.00
Ask: 235.00
Change: 0.50 (0.21%)
Spread: 3.00 (1.293%)
Open: 232.50
High: 233.50
Low: 232.50
Prev. Close: 233.00
DATA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Announcement of Investor Seminar

11 Jan 2024 07:00

RNS Number : 3183Z
GlobalData PLC
11 January 2024
 

11 January 2024

 

GlobalData Plc

(AIM: DATA, "GlobalData", the "Group")

 

Full year trading update and announcement of Investor Seminar

 

GlobalData Plc, a leading data, analytics, and insights platform, today provides the following update on trading following the end of its financial year to 31 December 2023 ("FY2023").

 

Following its interim results on 31 July 2023, GlobalData continued to deliver strong profitable growth throughout the second half. For FY2023, the Group expects to deliver Group revenue of c.£273m (2022: £243m), reflecting annual growth of 12% (7% underlying), and adjusted EBITDA growth of 28% to c.£111m (2022: £86m), which is within range of market expectations for the year. EBITDA margin was strong at c.41% (2022: 36%).

 

On 21 December 2023, we announced the launch of our new growth plan and Group reorganisation to operate across three customer-focused divisions - Healthcare, Consumer, and Technology - and also the transaction to sell a minority stake in our Healthcare business, which accounted for c.36% of revenue, at a valuation of £1,115m, raising net cash proceeds of approximately £434m.The transaction, which will provide flexibility for accelerated value-creating M&A across the Group, is progressing in line with our expectations and we expect to complete in Q2 2024.

 

GlobalData will host an investor and analyst seminar to focus on the new growth strategy and the customer-focused divisions, as well as further information on the impact of the Healthcare transaction on 24 January 2024 at 2pm. Please register your interest to attend this event with globaldata@fticonsulting.com.

 

FY2023 results, in full, will be announced on 4 March 2024.

 

Mike Danson, Chief Executive Officer of GlobalData Plc, commented:

 

"Over the last year, GlobalData has continued to execute on its growth optimisation plan and provide its global customer base with mission-critical insights and analysis. The result of this is we exited 2023 with another period of strong profitable growth and an EBITDA margin of more than 40%.

 

As we look ahead, we enter 2024 with a new growth plan and operating structure, which when added to our strong financial position, allows GlobalData to pursue a more ambitious growth strategy across the three divisions and create substantial value over the medium term."

 

 

ENDS

 

 

ENQUIRIES

 

GlobalData Plc

Mike Danson, Chief Executive Officer

0207 936 6400

Graham Lilley, Chief Financial Officer

J.P. Morgan Cazenove (Nomad, Joint Broker)

0203 493 8000

Bill Hutchings

Mose Adigun

Panmure Gordon (Joint Broker)

0207 886 2500

Rupert Dearden

Dougie McLeod

Deutsche Numis Securities (Joint Broker)

Nick Westlake

Iqra Amin

 

0207 260 1000

FTI Consulting (Financial PR)

0203 727 1000

Edward Bridges

Dwight Burden

Emma Hall

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFAESSELSEDF
Date   Source Headline
28th Feb 20227:00 amRNSFinal Year Results
24th Feb 20227:00 amRNSHolding(s) in Company
14th Jan 20224:43 pmRNSPDMR Notification
10th Jan 20227:00 amRNSUpdate on FY21 performance and Capital Markets Day
15th Dec 20217:00 amRNSAcquisition of Automotive and Agribusiness Assets
9th Sep 20217:00 amRNSAcquisition of Life Sciences business
28th Jul 20219:09 amRNSPDMR Notification
26th Jul 20217:00 amRNSUnaudited interim report
2nd Jul 202112:27 pmRNSInterim Accounts
24th Jun 202110:37 amRNSBoard Change
1st Jun 20214:26 pmRNSPDMR Dealing
30th Apr 20217:00 amRNSBoard Change
20th Apr 202110:56 amRNSResults of AGM
26th Mar 20217:00 amRNSNotice of AGM and the proposed appointment of NED
26th Mar 20217:00 amRNSInterim Accounts
15th Mar 20217:00 amRNSAnnual Report
1st Mar 20217:01 amRNSBoard Changes
1st Mar 20217:00 amRNSFinal Results For The Year Ended 31 December 2020
12th Feb 20214:12 pmRNSHolding(s) in Company
18th Jan 20219:17 amRNSDirector/PDMR Shareholding
5th Jan 20217:00 amRNSBoard Changes
21st Dec 20209:49 amRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSAppointment of Nomad and Broker
25th Nov 20207:00 amRNSTrading Update
9th Oct 20203:47 pmRNSTransfer of Shares out of Treasury
1st Sep 202012:16 pmRNSHolding(s) in Company
21st Aug 20208:55 amRNSAppointment of Joint Corporate Broker
27th Jul 20207:00 amRNSUnaudited Interim Report
21st May 20204:10 pmRNSEmployee Share Options and PDMR Dealing
19th May 20201:06 pmRNSIncreased Banking Facilities
21st Apr 202011:05 amRNSResults of AGM
21st Apr 20207:00 amRNSCOVID-19 Update, Dividend Deferral and AGM
27th Mar 202011:55 amRNSNotice of AGM
3rd Mar 20207:45 amRNSAnnual Report and Accounts
24th Feb 20207:00 amRNSFinal Results For The Year Ended 31 December 2019
16th Jan 20207:00 amRNSUpdate on Directorate Change
30th Oct 201910:59 amRNSHolding(s) in Company
3rd Oct 20197:00 amRNSDirectorate Change
29th Jul 20197:00 amRNSUnaudited Interim Report
19th Jul 20197:00 amRNSNotice of Results
23rd May 20197:00 amRNSNotice of Capital Markets Day
26th Apr 201912:57 pmRNSDirector/PDMR Dealings
23rd Apr 20194:20 pmRNSResults of AGM
28th Mar 20197:00 amRNSAnnual Report and Accounts and Notice of AGM
11th Mar 201911:41 amRNSPDMR Dealing
25th Feb 20197:00 amRNSFinal Results For The Year Ended 31 December 2018
17th Oct 20182:47 pmRNSHolding(s) in Company
30th Jul 20187:00 amRNSUnaudited Interim Report
4th May 20181:20 pmRNSDirector/PDMR Shareholding
30th Apr 20182:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.